loadpatents
Patent applications and USPTO patent grants for Bedian; Vahe.The latest application filed is for "compositions and methods for treatment of thyroid eye disease".
Patent | Date |
---|---|
Compositions And Methods For Treatment Of Thyroid Eye Disease App 20220275096 - Bedian; Vahe ;   et al. | 2022-09-01 |
Compositions And Methods For Treatment Of Thyroid Eye Disease App 20220267451 - Bedian; Vahe ;   et al. | 2022-08-25 |
Compositions And Methods For Treatment Of Thyroid Eye Disease App 20220267450 - Bedian; Vahe ;   et al. | 2022-08-25 |
Compositions And Methods For Treatment Of Thyroid Eye Disease App 20220235137 - Bedian; Vahe ;   et al. | 2022-07-28 |
Antibodies To M-csf App 20190202905 - Bedian; Vahe ;   et al. | 2019-07-04 |
Stabilized angiopoietin-2 antibodies and uses thereof Grant 10,329,345 - Bedian , et al. | 2019-06-25 |
Antibodies to M-CSF Grant 10,280,219 - Bedian , et al. | 2019-05-07 |
Antibodies To M-csf App 20170275354 - Bedian; Vahe ;   et al. | 2017-09-28 |
Antibodies to M-CSF Grant 9,718,883 - Bedian , et al. August 1, 2 | 2017-08-01 |
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20170174756 - BEDIAN; VAHE ;   et al. | 2017-06-22 |
Antibodies To M-csf App 20160244519 - Bedian; Vahe ;   et al. | 2016-08-25 |
Antibodies To Cd40 App 20160152713 - Bedian; Vahe ;   et al. | 2016-06-02 |
Human monoclonal antibodies to activin receptor-like kinase-1 Grant 9,221,915 - Belouski , et al. December 29, 2 | 2015-12-29 |
Nucleic acid molecule encoding target antibodies directed to DLL4 Grant 9,206,255 - Foltz , et al. December 8, 2 | 2015-12-08 |
Antibodies Directed To Alpha V Beta 6 And Uses Thereof App 20150166663 - RINKENBERGER; JULIE ;   et al. | 2015-06-18 |
Antibodies directed to .alpha.V.beta.6 and uses thereof Grant 8,894,998 - Rinkenberger , et al. November 25, 2 | 2014-11-25 |
Anti-cxcr4 Antibodies And Methods Of Use App 20140314784 - Bedian; Vahe ;   et al. | 2014-10-23 |
Treatment methods using c-Met antibodies Grant 8,821,869 - Michaud , et al. September 2, 2 | 2014-09-02 |
Targeted Binding Agents Directed To Dll4 And Uses Thereof App 20140206853 - Foltz; Ian ;   et al. | 2014-07-24 |
TREATMENT METHODS USING c-MET ANTIBODIES App 20140086914 - MICHAUD; NEIL R. ;   et al. | 2014-03-27 |
Method of treating a malignant tumor by administering antibodies directed to DLL4 Grant 8,663,636 - Foltz , et al. March 4, 2 | 2014-03-04 |
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20130280251 - Bedian; Vahe ;   et al. | 2013-10-24 |
Antibodies to c-Met Grant 8,562,985 - Michaud , et al. October 22, 2 | 2013-10-22 |
Stabilized angiopoietin-2 antibodies and uses thereof Grant 8,507,656 - Bedian , et al. August 13, 2 | 2013-08-13 |
Antibodies Directed To Alpha V Beta 6 And Uses Thereof App 20130202621 - Rinkenberger; Julie ;   et al. | 2013-08-08 |
Antibodies directed to .alpha.V.beta.6 and uses thereof Grant 8,398,975 - Rinkenberger , et al. March 19, 2 | 2013-03-19 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Grant 8,388,971 - Bedian , et al. March 5, 2 | 2013-03-05 |
Antibodies To Cd40 App 20130024956 - Bedian; Vahe ;   et al. | 2013-01-24 |
Antibodies To C-met App 20120321614 - Michaud; Neil R. ;   et al. | 2012-12-20 |
Cd40 Antibody Formulation And Methods App 20120263732 - Gladue; Ronald P. ;   et al. | 2012-10-18 |
Antibodies To M-csf App 20120244167 - Bedian; Vahe ;   et al. | 2012-09-27 |
Antibodies To Cd40 App 20120225014 - Bedian; Vahe ;   et al. | 2012-09-06 |
Targeted Binding Agents Directed To Dll4 And Uses Thereof 524 App 20120195905 - Bedian; Vahe ;   et al. | 2012-08-02 |
Targeted antibodies directed to DLL4 Grant 8,192,738 - Bedian , et al. June 5, 2 | 2012-06-05 |
Nucleic acid molecules encoding antibodies to M-CSF Grant 8,188,249 - Bedian , et al. May 29, 2 | 2012-05-29 |
Antibodies to c-Met Grant 8,163,280 - Michaud , et al. April 24, 2 | 2012-04-24 |
Human Monoclonal Antibodies To Activin Receptor-like Kinase-1 App 20120052074 - Belouski; Shelley Sims ;   et al. | 2012-03-01 |
Targeted binding agents directed to KDR and uses thereof--035 Grant 8,119,130 - Barry , et al. February 21, 2 | 2012-02-21 |
Human monoclonal antibodies to activin receptor-like kinase-1 Grant 8,080,646 - North , et al. December 20, 2 | 2011-12-20 |
Cd40 Antibody Formulation And Methods App 20110104182 - Gladue; Ronald P. ;   et al. | 2011-05-05 |
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20110044998 - Bedian; Vahe ;   et al. | 2011-02-24 |
Antibodies Directed to Alpha V Beta 6 And Uses Thereof App 20100330103 - RINKENBERGER; Julie ;   et al. | 2010-12-30 |
Targeted Binding Agents Directed To Kdr And Uses Thereof - 035 App 20100260765 - Barry; Simon Thomas ;   et al. | 2010-10-14 |
Antibodies To M-csf App 20100247545 - Bedian; Vahe ;   et al. | 2010-09-30 |
Human Monoclonal Antibodies To Activin Receptor-like Kinase-1 App 20100197005 - Belouski; Shelley Sims ;   et al. | 2010-08-05 |
Targeted Binding Agents Directed To Dll4 And Uses Thereof 524 App 20100196385 - Bedian; Vahe ;   et al. | 2010-08-05 |
Methods of treating arthritic conditions with antibodies to M-CSF Grant 7,728,113 - Bedian , et al. June 1, 2 | 2010-06-01 |
Antibodies To Cd40 App 20100098694 - Bedian; Vahe ;   et al. | 2010-04-22 |
Cd44 Antibodies App 20100092484 - Xu; Xu ;   et al. | 2010-04-15 |
Antibodies to c-Met App 20100040629 - Michaud; Neil R. ;   et al. | 2010-02-18 |
Cd40 Antibody Formulation And Methods App 20090311254 - Gladue; Ronald P. ;   et al. | 2009-12-17 |
Nucleic acid molecules which encode antibodies that bind CD40 Grant 7,626,012 - Bedian , et al. December 1, 2 | 2009-12-01 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Grant 7,618,633 - Bedian , et al. November 17, 2 | 2009-11-17 |
Antibodies to M-CSF Grant 7,592,430 - Bedian , et al. September 22, 2 | 2009-09-22 |
Modified human IGF-IR antibodies Grant 7,575,746 - Cohen , et al. August 18, 2 | 2009-08-18 |
Antibodies to CD40 and methods of treating cancer and enhancing immune responses Grant 7,563,442 - Bedian , et al. July 21, 2 | 2009-07-21 |
Antibodies to CD40 App 20090169563 - Bedian; Vahe ;   et al. | 2009-07-02 |
Human monoclonal antibodies to activin receptor-like kinase-1 Grant 7,537,762 - North , et al. May 26, 2 | 2009-05-26 |
Antibodies to CD40 App 20090130715 - Bedian; Vahe ;   et al. | 2009-05-21 |
Antibodies to c-Met Grant 7,498,420 - Michaud , et al. March 3, 2 | 2009-03-03 |
Antibodies to M-CSF App 20080254032 - Bedian; Vahe ;   et al. | 2008-10-16 |
Modified Human Igf-ir Antibodies App 20080181891 - Cohen; Bruce D. ;   et al. | 2008-07-31 |
Modified human IGF-IR antibodies Grant 7,371,378 - Cohen , et al. May 13, 2 | 2008-05-13 |
Antibodies Directed to AlphaVBeta6 and Uses Thereof App 20080057063 - Rinkenberger; Julie ;   et al. | 2008-03-06 |
Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 Grant 7,338,660 - Bedian , et al. March 4, 2 | 2008-03-04 |
Antibodies to M-CSF Grant 7,326,414 - Bedian , et al. February 5, 2 | 2008-02-05 |
Antibodies to CD40 Grant 7,288,251 - Bedian , et al. October 30, 2 | 2007-10-30 |
Antibodies to CD40 App 20070190051 - Bedian; Vahe ;   et al. | 2007-08-16 |
Human monoclonal antibodies to activin receptor-like kinase-1 App 20070065444 - North; Michael Aidan ;   et al. | 2007-03-22 |
Antibodies to M-CSF App 20060153850 - Bedian; Vahe ;   et al. | 2006-07-13 |
Antibodies to CD40 App 20060093600 - Bedian; Vahe ;   et al. | 2006-05-04 |
CD40 antibody formulation and methods App 20050136055 - Gladue, Ronald P. ;   et al. | 2005-06-23 |
Modified human IGF-IR antibodies App 20050069539 - Cohen, Bruce D. ;   et al. | 2005-03-31 |
Antibodies to M-CSF App 20050059113 - Bedian, Vahe ;   et al. | 2005-03-17 |
Antibodies to c-Met App 20050054019 - Michaud, Neil R. ;   et al. | 2005-03-10 |
Uses of anti-insulin-like growth factor 1 receptor antibodies App 20040202651 - Cohen, Bruce D. ;   et al. | 2004-10-14 |
Point of care test for measurement of therapeutic drug levels App 20030211636 - Bedian, Vahe ;   et al. | 2003-11-13 |
Antibodies to CD40 App 20030211100 - Bedian, Vahe ;   et al. | 2003-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.